---
schema_version: "secwatch.filing_event.v1"
accession: "0000320017-25-000033"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2025-06-10T23:59:59+00:00"
generated_at: "2026-05-19T16:21:53.441037+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lisata shareholders re-elect Azab, Klosk; approve ESPP, auditor, say-on-pay, one-year frequency

## Summary
- Re-elected Mohammad Azab (3,809,977 for) and Steven Klosk (3,788,000 for) as Class III directors to 2028.
- Approved amendment to 2017 ESPP increasing shares from 113,333 to 158,333 (3,523,229 for, 294,116 against, 378,495 abstain).
- Ratified Grant Thornton LLP as independent auditor for FY2025 (6,226,674 for, 64,171 against, 136,348 abstain).
- Non-binding advisory votes: approved executive compensation (3,496,571 for) and selected one-year frequency for future say-on-pay votes (3,967,202 for one year).

## SEC filing metadata
- accession: 0000320017-25-000033
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2025-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000032001725000033/0000320017-25-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000032001725000033/clbs-20250610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000320017-25-000033
- JSON: https://secwatch.observer/filing/0000320017-25-000033.json
- Plain text: https://secwatch.observer/filing/0000320017-25-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.